Skip to main content

8-K

Cencora, Inc. (COR)

8-K 2025-03-10 For: 2025-03-06
View Original
Added on April 10, 2026

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or15(d)

of theSecurities Exchange Act of 1934

Date of Report (Date of earliest event reported): March 6, 2025

Cencora,

Inc.

(Exact name of registrant as specified in its charter)

Commission File Number:

1-6671

Delaware 23-3079390
(State or other jurisdiction of (I.R.S. Employer
incorporation or organization) Identification No.)
1 West First Avenue Conshohocken PA 19428-1800
(Address of principal executive offices) (Zip Code)

(610)

727-7000

(Registrant’s telephone number, including area code) ****

Not Applicable

(Former name or former address, if changed since last report.)

Securities registered pursuant to Section 12(b)of the Act:

Title of each class Trading Symbol(s) Name of exchange on which registered
Common<br> stock COR New<br> York Stock Exchange (NYSE)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

¨  Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

¨  Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

¨  Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

¨  Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company     ¨

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.     ¨

Item 5.07. Submission of Matters to a Vote of Security Holders.
(a) Cencora, Inc. (the “Company”) held its 2025 Annual Meeting of Shareholders (the “Annual Meeting”) on March 6,<br>2025.
--- ---
(b) Each of the three items listed below was submitted to a vote of the Company's shareholders at the Annual Meeting and is described in more<br>detail in the definitive proxy statement filed by the Company with the Securities and Exchange Commission on January 23, 2025 (the “Proxy<br>Statement”). The final voting results are set forth below:
--- ---

Item 1 - Election of Directors.

Each of the individuals listed below was elected by the Company’s shareholders.

Nominees For Against Abstentions Broker Non-Votes
Ornella Barra 168,413,582 762,532 166,952 9,542,398
Werner Baumann 165,837,072 3,354,227 151,767 9,542,398
Frank K. Clyburn 167,730,172 1,458,056 154,838 9,542,398
Steven H. Collis 165,458,442 3,759,064 125,560 9,542,398
D. Mark Durcan 168,590,464 597,571 155,031 9,542,398
Lon R. Greenberg 153,366,924 15,673,799 302,343 9,542,398
Lorence H. Kim, M.D. 167,048,677 2,132,892 161,497 9,542,398
Robert P. Mauch 167,590,712 1,597,295 155,059 9,542,398
Redonda G. Miller, M.D. 164,014,442 5,165,281 163,343 9,542,398
Dennis M. Nally 166,267,786 2,918,693 156,587 9,542,398
Lauren M. Tyler 161,743,928 7,426,800 172,338 9,542,398

Item 2 - Advisory Vote to Approve the Compensation of the Company’s

Named Executive Officers.

The Company’s shareholders approved this item. The voting results were as follows:

For Against Abstentions Broker Non-Votes
156,885,713 12,269,867 187,486 9,542,398

Item 3 - Ratification of Appointment of Ernst & Young LLP as

the Company’s Independent Registered Public Accounting Firm for Fiscal Year 2025.

The Company’s shareholders approved this item. The voting results were as follows:

For Against Abstentions Broker Non-Votes
166,297,099 12,410,706 177,659 N/A

No item other than the three items addressed above and described in the Proxy Statement was submitted at the Annual Meeting for shareholder action.


SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

Cencora, Inc.
March 10, 2025 By: /s/ Elizabeth S. Campbell
Name: Elizabeth S.<br> Campbell
Title: Executive Vice President and Chief Legal Officer